Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

RECENT NEWS

June 15, 2017 Vical to Provide Company Update at the 2017 BIO International Convention
June 5, 2017 Vical Presents Phase 1 VL-2397 Data at the June ASM Microbe 2017 Meeting Supporting Advancement to Phase 2

June 15, 2017
Vical to Provide Company Update at the 2017 BIO International Convention

June 5, 2017
Vical Presents Phase 1 VL-2397 Data at the June ASM Microbe 2017 Meeting Supporting Advancement to Phase 2

EVENTS & PRESENTATIONS

June 21, 2017 Vical Provides Company Update at the 2017 BIO International Convention View the Webcast
May 15, 2017 Vical Inc. 1Q17 Financial Results Conference Call View the Webcast

June 21, 2017
Vical Provides Company Update at the 2017 BIO International Convention

May 15, 2017
Vical Inc. 1Q17 Financial Results Conference Call

PRODUCT PIPELINE

CONNECT WITH US

RSS Feeds
Email Alerts
LinkedIn
Slideshare
StockTwits
Twitter
YouTube

Privacy Policy
Terms of Use
Site Map

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121

This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.